SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+1.06%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.2B
AUM Growth
+$1.2B
(-2.7%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20
Top Buys
| 1 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$40.5M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$23.5M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$23.4M |
| 4 |
Health Catalyst
HCAT
|
$22.1M |
| 5 |
Rapid Micro Biosystems
RPID
|
$9.44M |
Top Sells
| 1 |
Repligen
RGEN
|
$22.5M |
| 2 |
Teleflex
TFX
|
$21.1M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$20.4M |
| 4 |
OSH
Oak Street Health, Inc.
OSH
|
$18.8M |
| 5 |
NeueHealth
NEUE
|
$15.7M |
Sector Composition
| 1 | Healthcare | 94.67% |
| 2 | Industrials | 4.36% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
PTC Therapeutics
PTCT
$4.41B
| $9.39M | 0.78% |
252,291
-80,000
| -24% | -$2.98M |
|
52
Olema Pharmaceuticals
OLMA
$432M
| $9.33M | 0.78% |
338,381
-151,639
| -31% | -$4.18M |
|
53
Rallybio
RLYB
$24.1M
| $9.27M | 0.77% |
+527,136
| New | +$9.27M |
|
|
TPTX
54
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.08M | 0.76% |
136,650
-75,000
| -35% | -$4.98M |
|
55
DexCom
DXCM
$30.9B
| $8.99M | 0.75% |
16,438
-9,850
| -37% | -$5.39M |
|
|
ACCD
56
DELISTED
Accolade, Inc. Common Stock
ACCD
| $8.86M | 0.74% |
210,000
-20,000
| -9% | -$843K |
|
57
Abbott
ABT
$230B
| $8.8M | 0.73% |
74,448
-19,500
| -21% | -$2.3M |
|
|
58
Teleflex
TFX
$5.57B
| $8.76M | 0.73% |
23,261
-56,107
| -71% | -$21.1M |
|
59
Bio-Techne
TECH
$8.3B
| $8.53M | 0.71% |
+17,600
| New | +$8.53M |
|
60
Intellia Therapeutics
NTLA
$1.26B
| $8.44M | 0.7% |
+62,900
| New | +$8.44M |
|
61
Molina Healthcare
MOH
$9.6B
| $8.33M | 0.69% |
30,697
| – | – |
|
|
CELL
62
DELISTED
PhenomeX Inc. Common Stock
CELL
| $8.25M | 0.69% |
+421,535
| New | +$8.25M |
|
63
BioMarin Pharmaceuticals
BMRN
$11.3B
| $8.2M | 0.68% |
106,112
+33,390
| +46% | +$2.58M |
|
64
Guardant Health
GH
$8.11B
| $8.17M | 0.68% |
65,386
-6,800
| -9% | -$850K |
|
65
Exelixis
EXEL
$9.95B
| $8.1M | 0.67% |
383,370
-35,000
| -8% | -$740K |
|
|
66
Repligen
RGEN
$6.54B
| $7.8M | 0.65% |
27,000
-77,793
| -74% | -$22.5M |
|
|
ITOS
67
DELISTED
iTeos Therapeutics
ITOS
| $7.39M | 0.61% |
273,700
+266,000
| +3,455% | +$7.18M |
|
|
JBIO
68
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $7.16M | 0.6% |
341,367
-158,633
| -32% | -$3.33M |
|
69
Hologic
HOLX
$14.7B
| $7.07M | 0.59% |
95,800
-500
| -0.5% | -$36.9K |
|
70
Neuropace
NPCE
$310M
| $7.05M | 0.59% |
444,572
-27,394
| -6% | -$434K |
|
71
Centene
CNC
$14.8B
| $7.05M | 0.59% |
113,075
-40,900
| -27% | -$2.55M |
|
72
Cytek Biosciences
CTKB
$501M
| $7.02M | 0.58% |
+328,080
| New | +$7.02M |
|
73
Teladoc Health
TDOC
$1.37B
| $6.74M | 0.56% |
53,138
+2,500
| +5% | +$317K |
|
|
KLRS
74
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $6.6M | 0.55% |
263,375
+228,425
| +654% | +$5.72M |
|
75
Dentsply Sirona
XRAY
$2.77B
| $6.56M | 0.55% |
113,000
+5,000
| +5% | +$290K |
|